Skip to main content
Clinical Trials/NCT01238341
NCT01238341
Completed
Not Applicable

Prospective Evaluation of Clinical Utility of Endoscopic Retrograde Cholangiopancreatography (ERCP) With Overtube in Patients With Altered Gastric Anatomy

University of Florida1 site in 1 country7 target enrollmentJune 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pancreatobiliary Disease
Sponsor
University of Florida
Enrollment
7
Locations
1
Primary Endpoint
Papilla or Duct-enterostomy Was Reached
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

In patients, who have altered gastric anatomy and pancreatobiliary disease, the use of an endoscopic overtube to facilitate an Endoscopic Retrograde Cholangiopancreatography (ERCP).

Registry
clinicaltrials.gov
Start Date
June 2007
End Date
July 2015
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subject is 18 years or older
  • Subject has medical indication for Endoscopic Retrograde Cholangiopancreatography (ERCP)
  • Subject has altered gastric anatomy
  • Subject must be able to give informed consent.

Exclusion Criteria

  • Any contraindication for Endoscopic Retrograde Cholangiopancreatography (ERCP) with overtube
  • The subject is unable to give informed consent

Outcomes

Primary Outcomes

Papilla or Duct-enterostomy Was Reached

Time Frame: During procedure, up to 3 hours

Secondary Outcomes

  • Successful Cannulation of the Duct of Intent(During procedure, up to 3 hours)
  • Successful Endoscopic Therapy(During procedure, up to 3 hours)
  • Total Procedure Time(During procedure, up to 3 hours)

Study Sites (1)

Loading locations...

Similar Trials